Literature DB >> 19298350

An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.

Takuya Koie1, Takahiro Yoneyama, Yasuhiro Hashimoto, Noritaka Kamimura, Tomomi Kusumi, Hiroshi Kijima, Chikara Ohyama.   

Abstract

Cases of renal cell carcinoma (RCC) associated with Xp11 translocations are rare and are reported predominantly in children. We report a case of a young man who developed an aggressive Xp11 translocation RCC. A 28-year-old man presented with back pain, fever and macroscopic hematuria. Computed tomography of the abdomen showed a heterogeneous mass in the left kidney. Left radical nephrectomy was performed. Hematoxylin-eosin staining revealed nested and papillary architecture, clear and eosinophilic cytoplasm and vesicles with prominent nucleoli. Immunohistochemical evaluation revealed that the tumor cells showed nuclear labeling for TFE3 protein. On the basis of these findings, the case was diagnosed as Xp11 translocation RCC. This tumor massively recurred and led to the patient's death 2 years after the initial diagnosis. The utility of immunohistochemistry using antibodies against TFE3 in RCC occurring in young adults may be necessary for accurate diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298350     DOI: 10.1111/j.1442-2042.2008.02231.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  Genomic heterogeneity of translocation renal cell carcinoma.

Authors:  Gabriel G Malouf; Federico A Monzon; Jérôme Couturier; Vincent Molinié; Bernard Escudier; Philippe Camparo; Xiaoping Su; Hui Yao; Pheroze Tamboli; Dolores Lopez-Terrada; Maria Picken; Marileila Garcia; Asha S Multani; Sen Pathak; Christopher G Wood; Nizar M Tannir
Journal:  Clin Cancer Res       Date:  2013-07-01       Impact factor: 12.531

Review 2.  Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas.

Authors:  Qiu Rao; Qiu-Yuan Xia; Liang Cheng; Xiao-Jun Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report.

Authors:  Akihiro Morii; Yasuyoshi Fujiuchi; Kazuhiro Nomoto; Akira Komiya; Hideki Fuse
Journal:  J Med Case Rep       Date:  2012-06-27

4.  TFE3 Translocation-Associated Renal Cell Carcinoma Presenting as Avascular Necrosis of the Femur in a 19-Year-Old Patient: Case Report and Review of the Literature.

Authors:  T Nelius; I Al-Khalil; J Vordermark; K Rinard-Holden; T Cammack; V Mamlok; S Filleur
Journal:  Case Rep Med       Date:  2011-10-05

Review 5.  Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies.

Authors:  Xiangming Cheng; Weidong Gan; Gutian Zhang; Xiaogong Li; Hongqian Guo
Journal:  BMC Urol       Date:  2016-07-11       Impact factor: 2.264

6.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

7.  Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.

Authors:  Henry B Armah; Anil V Parwani; Urvashi Surti; Sheldon I Bastacky
Journal:  Diagn Pathol       Date:  2009-05-18       Impact factor: 2.644

8.  Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Dinesh Pradhan; Somak Roy; Gabriela Quiroga-Garza; Kathleen Cieply; Alyssa L Mahaffey; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644

9.  MiT translocation renal cell carcinomas: two subgroups of tumours with translocations involving 6p21 [t (6; 11)] and Xp11.2 [t (X;1 or X or 17)].

Authors:  Milan Hora; Tomáš Urge; Ivan Trávníček; Jiří Ferda; Zdeněk Chudáček; Tomáš Vaněček; Michal Michal; Fredrik Petersson; Naoto Kuroda; Ondřej Hes
Journal:  Springerplus       Date:  2014-05-13

10.  Clinicopathological features of Xp11.2 translocation renal cell carcinoma.

Authors:  Bumjin Lim; Dalsan You; In Gab Jeong; Taekmin Kwon; Sungwoo Hong; Cheryn Song; Yong Mee Cho; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn; Choung Soo Kim
Journal:  Korean J Urol       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.